Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 0904-6293

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 0904-6293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 01

A line graph depicting cumulative incidence (%) over time in years comparing Atorvastatin and placebo groups. The solid line represents Atorvastatin, showing lower cumulative incidence than the dashed placebo line. The graph covers a 0 to 3.5 year period and includes a hazard ratio (HR=0.64) with confidence interval and p-value.*

FDA Label Image

Figure 02

A line graph depicting cumulative hazard percentage over time in years up to 5 years. It compares the cumulative hazard for Atorvastatin versus placebo, showing a lower cumulative hazard for Atorvastatin over the follow-up period.*

FDA Label Image

Figure 03

A line graph depicting the time to first major cardiovascular event over a 5-year period for subjects treated with Atorvastatin 10 mg and 80 mg. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR 0.78) with confidence interval and p-value indicating statistical significance.*

FDA Label Image

Chemical Structure

Chemical structure of atorvastatin calcium showing two calcium ions complexed with atorvastatin molecules. The diagram depicts molecular bonds and functional groups typical for this active pharmaceutical ingredient.*

FDA Label Image

Image 01

Label for ATORVASTATIN CALCIUM tablets, USP 40 mg film-coated oral tablets by Major Pharmaceuticals. The label indicates unit dose packaging with 100 tablets, designated for prescription use only. The label includes storage instructions, dispensing advice, and manufacturer and distributor addresses along with the NDC 0904-6292-61 barcode.*

FDA Label Image

Image 02

The packaging label for ATORVASTATIN CALCIUM tablets, USP by Major Pharmaceuticals shows a unit dose package with a strength of 80 mg. The label states the product contains 30 film-coated tablets intended for oral use and prescription only. It includes storage instructions, dispensing advisory, and manufacturer information from Toronto, Ontario, and Apotex Corp in Florida, with distribution by Major Pharmaceuticals in Michigan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.